The GlucoWatch(R) (Cygnus, Inc, Redwood City, CA, USA) biographer provides
automatic, frequent and noninvasive blood glucose measurements for up to 12
h. The device extracts glucose through intact skin where it is measured by
an amperometric biosensor. Clinical trials in a variety of environments ha
ve shown that the biographer provides accurate and precise glucose measurem
ents when compared with serial fingerstick blood glucose measurements. Mean
difference between these measurements was 0.26 mmol/L in the home environm
ent (r = 0.80). Over 94% of biographer readings were in the clinically acce
ptable A+B region of the Clarke Error Grid. A slight positive bias is obser
ved for the biographer readings at low glucose levels. Biographer precision
, as measured by coefficient of variation (CV)%, is approximately 10%. The
low glucose alert function of the biographer was able to detect up to 75% o
f hypoglycaemic episodes with a low false alert level. Skin irritation, cha
racterized by erythema and oedema was either nonexistent or mild in over 87
% of subjects and resolved in virtually all subjects without treatment in s
everal days. The GlucoWatch(R) biographer has been shown to be a safe and e
ffective method to track glucose level trends and patterns, which should en
able improved glycaemic control for many patients.